59 related articles for article (PubMed ID: 38691867)
21. Chordoma: a case series and review of the literature.
Alan O; Akin Telli T; Ercelep O; Tanrikulu Simsek E; Basoglu Tuylu T; Mutis A; Hasanov R; Kaya S; Akgül Babacan N; Dane F; Yumuk PF
J Med Case Rep; 2018 Aug; 12(1):239. PubMed ID: 30145982
[TBL] [Abstract][Full Text] [Related]
22. Medical treatment of advanced chordomas.
Colia V; Stacchiotti S
Eur J Cancer; 2017 Sep; 83():220-228. PubMed ID: 28750274
[TBL] [Abstract][Full Text] [Related]
23. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
24. Skull base chordomas review of current treatment paradigms.
Yaniv D; Soudry E; Strenov Y; Cohen MA; Mizrachi A
World J Otorhinolaryngol Head Neck Surg; 2020 Jun; 6(2):125-131. PubMed ID: 32596658
[TBL] [Abstract][Full Text] [Related]
25. Novel targeted therapies in chordoma: an update.
Di Maio S; Yip S; Al Zhrani GA; Alotaibi FE; Al Turki A; Kong E; Rostomily RC
Ther Clin Risk Manag; 2015; 11():873-83. PubMed ID: 26097380
[TBL] [Abstract][Full Text] [Related]
26. Tumor-biology and current treatment of skull-base chordomas.
Pamir MN; Ozduman K
Adv Tech Stand Neurosurg; 2008; 33():35-129. PubMed ID: 18383812
[TBL] [Abstract][Full Text] [Related]
27. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
28. Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
Bednova O; Leyton JV
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019653
[TBL] [Abstract][Full Text] [Related]
29. The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients.
Barry JJ; Jian BJ; Sughrue ME; Kane AJ; Mills SA; Tihan T; Parsa AT
Neurosurgery; 2011 Jan; 68(1):231-40; discussion 240-1. PubMed ID: 21099719
[TBL] [Abstract][Full Text] [Related]
30. Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma.
Chen Y; Hu H; Yuan X; Fan X; Zhang C
Front Immunol; 2022; 13():896752. PubMed ID: 35757756
[TBL] [Abstract][Full Text] [Related]
31. Shedding light on emerging therapeutic targets for chordoma.
Martinez Moreno M; Wang E; Schroeder C; Sullivan P; Gokaslan Z
Expert Opin Ther Targets; 2023; 27(8):705-713. PubMed ID: 37647357
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review.
Wang X; Chen Z; Li B; Fan J; Xu W; Xiao J
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612259
[TBL] [Abstract][Full Text] [Related]
33. Systemic therapy options for unresectable and metastatic chordomas.
Stacchiotti S; Casali PG
Curr Oncol Rep; 2011 Aug; 13(4):323-30. PubMed ID: 21584646
[TBL] [Abstract][Full Text] [Related]
34. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
35. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
Gill CM; Fowkes M; Shrivastava RK
Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
[TBL] [Abstract][Full Text] [Related]
36. Surgical Management of Skull Base and Spine Chordomas.
Passer JZ; Alvarez-Breckenridge C; Rhines L; DeMonte F; Tatsui C; Raza SM
Curr Treat Options Oncol; 2021 Mar; 22(5):40. PubMed ID: 33743089
[TBL] [Abstract][Full Text] [Related]
37. The biological basis for modern treatment of chordoma.
Diaz RJ; Cusimano MD
J Neurooncol; 2011 Sep; 104(2):411-22. PubMed ID: 21384217
[TBL] [Abstract][Full Text] [Related]
38. The cutting-edge progress of immune-checkpoint blockade in lung cancer.
Zhou F; Qiao M; Zhou C
Cell Mol Immunol; 2021 Feb; 18(2):279-293. PubMed ID: 33177696
[TBL] [Abstract][Full Text] [Related]
39. Systemic treatment of advanced or recurrent biliary tract cancer.
Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
[TBL] [Abstract][Full Text] [Related]
40. Current opinion in otolaryngology and head and neck surgery: clival chordoma and its management.
Snyderman CH; Gardner PA
Curr Opin Otolaryngol Head Neck Surg; 2020 Apr; 28(2):118-121. PubMed ID: 32102007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
